Literature DB >> 17214917

Intravenous lidocaine for neuropathic pain: diagnostic utility and therapeutic efficacy.

Ian Carroll1.   

Abstract

Lidocaine is a use-dependent sodium channel blocker that produces analgesia when administered intravenously to patients with neuropathic pain. This article reviews the role and limitations of intravenous lidocaine infusions for neuropathic pain. Lidocaine infusions rarely provide relief that persists significantly beyond the duration of the infusion. Diagnostically, systemic lidocaine may help establish the presence of neuropathic pain and the responsivity to oral sodium channel blockade. However, the data supporting diagnostic infusions remain sparse. Therapeutically, infusions should generally be restricted to patients with neuropathic pain who are unable to take oral medication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17214917     DOI: 10.1007/s11916-007-0017-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  28 in total

1.  Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction.

Authors:  Marshall Devor; Patrick D Wall; Naor Catalan
Journal:  Pain       Date:  1992-02       Impact factor: 6.961

Review 2.  Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

Authors:  S L Collins; R A Moore; P Wiffen
Journal:  J Pain Symptom Manage       Date:  2000-12       Impact factor: 3.612

3.  Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat.

Authors:  C J Sinnott; J M Garfield; G R Strichartz
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

4.  The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers.

Authors:  J Dirks; P Fabricius; K L Petersen; M C Rowbotham; J B Dahl
Journal:  Anesth Analg       Date:  2000-10       Impact factor: 5.108

5.  Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study.

Authors:  B S Galer; J Harle; M C Rowbotham
Journal:  J Pain Symptom Manage       Date:  1996-09       Impact factor: 3.612

6.  Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury.

Authors:  B S Galer; K V Miller; M C Rowbotham
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

7.  Case report: limbic system activation by intravenous lidocaine in a patient with a complex regional pain syndrome and major depression.

Authors:  M S Leong; H B Solvason
Journal:  Pain Med       Date:  2000-12       Impact factor: 3.750

8.  Analgesic responses to i.v. lignocaine.

Authors:  R A Boas; B G Covino; A Shahnarian
Journal:  Br J Anaesth       Date:  1982-05       Impact factor: 9.166

9.  Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine.

Authors:  Palle Petersen; Jens Kastrup
Journal:  Pain       Date:  1987-01       Impact factor: 6.961

10.  Chronic pain treatment with intravenous lidocaine.

Authors:  P Petersen; J Kastrup; I Zeeberg; G Boysen
Journal:  Neurol Res       Date:  1986-09       Impact factor: 2.448

View more
  7 in total

Review 1.  Intravenous lidocaine and mexiletine in the management of trigeminal autonomic cephalalgias.

Authors:  Michael J Marmura
Journal:  Curr Pain Headache Rep       Date:  2010-04

2.  Continuous Lidocaine Infusion as Adjunctive Analgesia in Intensive Care Unit Patients.

Authors:  Yoonsun Mo; Michael C Thomas; Abigail D Antigua; Alex M Ebied; George E Karras
Journal:  J Clin Pharmacol       Date:  2017-02-07       Impact factor: 3.126

3.  Increased phosphorylation of extracellular signal-regulated kinase in trigeminal nociceptive neurons following propofol administration in rats.

Authors:  Emi Shoda; Junichi Kitagawa; Ikuko Suzuki; Ieko Nitta-Kubota; Makiko Miyamoto; Yoshiyuki Tsuboi; Masahiro Kondo; Yuji Masuda; Yoshiyuki Oi; Ke Ren; Koichi Iwata
Journal:  J Pain       Date:  2009-04-23       Impact factor: 5.820

Review 4.  Perioperative interventions to reduce chronic postsurgical pain.

Authors:  Ian Carroll; Jennifer Hah; Sean Mackey; Einar Ottestad; Jiang Ti Kong; Sam Lahidji; Vivianne Tawfik; Jarred Younger; Catherine Curtin
Journal:  J Reconstr Microsurg       Date:  2013-03-05       Impact factor: 2.873

Review 5.  Lidocaine Infusions for Pain Management in Pediatrics.

Authors:  Elizabeth A Hall; Hannah E Sauer; Margaret S Davis; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2021-05-26       Impact factor: 3.930

6.  Lidocaine infusions and reduced opioid consumption-Retrospective experience in pediatric hematology and oncology patients with refractory pain.

Authors:  Doralina L Anghelescu; Kyle J Morgan; Michael J Frett; Diana Wu; Yimei Li; Yuanyuan Han; Elizabeth A Hall
Journal:  Pediatr Blood Cancer       Date:  2021-07-15       Impact factor: 3.167

7.  Analgesic effects of adding lidocaine to morphine pumps after orthopedic surgeries.

Authors:  Mahmoud Reza Alebouyeh; Farnad Imani; Poupak Rahimzadeh; Saeed Reza Entezary; Seyed Hamid Reza Faiz; Parisa Soraya
Journal:  J Res Med Sci       Date:  2014-02       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.